Eidos Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Eidos Therapeutics, Inc.
CIK #0001731831
EDGAR Form CIK 2011 - 2024
10-K [0001731831]
10-Q [0001731831]
3 [0001731831]
4 [0001731831]
5 [0001731831]
8-K [0001731831]
D [0001731831]
SC 13D [0001731831]
SC 13G [0001731831]
Form 13D/13G Filer Form 13D/13G Subject Filed
Eidos Therapeutics Inc Bridgebio Pharma Inc [2020-10-15]
Bridgebio Pharma LLC Eidos Therapeutics Inc [2018-08-01]
Viking Global Investors LP Eidos Therapeutics Inc [2018-07-02]
RA Capital Management LLC Eidos Therapeutics Inc [2018-07-02]
Form 3/4/5 Subject 2011 - 2024
Eidos Therapeutics, Inc.
Sinha Uma
Fox Jonathan C
Rohlen Douglas
Valle Franco
Turtle Cameron
Satvat Ali J.
Lis William
Hooper Suzanne Sawochka
BridgeBio Pharma, Inc.
View All
Terms | Privacy | Guide
tony@aum13f.com